October 23, 2026

News, minutes after it breaks

Technology
Latest
The World Treadmill Championship – pitching elite runners against amateurs'I live in the dark': How rising bills are shaping daily lifeEmbarrassing name? How we live with names we don't likePowerful earthquake hits Tibet killing 16 people, reports say'Shock' of first England farmer hit by bird flu this seasonLive: Macron meets with student representatives and law enforcement ahead of new protestsBlue Planet III: Moment octopus escapes death after hunt gone wrongAppalachian St. ends James Madison's undefeated start to seasonThe World Treadmill Championship – pitching elite runners against amateurs'I live in the dark': How rising bills are shaping daily lifeEmbarrassing name? How we live with names we don't likePowerful earthquake hits Tibet killing 16 people, reports say'Shock' of first England farmer hit by bird flu this seasonLive: Macron meets with student representatives and law enforcement ahead of new protestsBlue Planet III: Moment octopus escapes death after hunt gone wrongAppalachian St. ends James Madison's undefeated start to season

Home  / Technology

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Technology Ars Technica
Image: Ars Technica

Markers released top-line results today after previously reporting the trial succeeded.

Ars Technica reported this story. Read the full report on arstechnica.com →

This is a short summary. Ars Technica wrote and published the full report.

Continue on arstechnica.com →

More in Technology

Leave a Reply

Your email address will not be published. Required fields are marked *